Martina Biggi

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST)

M. Gangitano, F. Ferreri, M. Tombini, 2022, Seizure.

Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)

M. Gangitano, F. Ferreri, M. Tombini, 2022, Drugs & Aging.

Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)

M. Gangitano, F. Ferreri, M. Tombini, 2021, CNS Drugs.

Prediction of seizure recurrence risk following discontinuation of antiepileptic drugs

M. Paganini, L. Massacesi, E. Rosati, 2021, Epilepsia.

Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study

M. Gangitano, F. Ferreri, M. Tombini, 2022, Neurology and Therapy.

Long-term-video monitoring EEG and 18F-FDG-PET are useful tools to detect residual disease activity in anti-LGI1-Abs encephalitis: A case report

V. Berti, L. Massacesi, E. Rosati, 2022, Frontiers in Neurology.